Stock Screener App
Free
-
Play Store
App Store
Install
Install
Dark
EN
Sign in
Watchlist
Top Lists
Markets
New
Options
Cryptos
Industries
Elite
Market Simulator
TSHA
$4.09
6.19%
-0.27
Taysha Gene Therapies Inc (TSHA)
Indicator
5
EX
1min
5min
Hourly
Daily
Weekly
Monthly
Line
Candle
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Similar to TSHA
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Taysha Gene Therapies Inc Stock (TSHA) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Period Length
3 Months
3 Months
3 Months
3 Months
3 Months
Revenues
-
-
5.49
-
1.99
Operating Expenses
8.88%
47.35
43.49
33.79
34.02
28.74
Research and Development
14.28%
38.64
33.81
24.95
25.75
20.14
Operating Income/Loss
8.88%
-47.35
-43.49
-28.30
-34.02
-26.75
Nonoperating Income/Loss
34.01%
0.71
1.08
0.45
1.29
-0.13
Income Tax Expense/Benefit
-
-
-
-
-
Net Income/Loss
9.97%
-46.64
-42.41
-27.85
-32.73
-26.88
Attributable To Parent
9.97%
-46.64
-42.41
-27.85
-32.73
-26.88
Available To Common Stockholders, Basic
9.97%
-46.64
-42.41
-27.85
-32.73
-26.88
Basic Average Shares
0.66%
369.04
366.63
-
353.31
297.99
Diluted Average Shares
0.66%
369.04
366.63
-
353.31
297.99
Basic Earnings Per Share
8.33%
-0.13
-0.12
-
-0.09
-0.09
Diluted Earnings Per Share
8.33%
-0.13
-0.12
-
-0.09
-0.09
